An FDA advisory panel recently voted to approve certain popular peptides, drawing considerable attention to their market. The decision has also sparked concerns regarding the currently unregulated supply of these products.

An advisory panel to the Food and Drug Administration is scheduled to meet this week to provide recommendations on whether specialized pharmacies should be permitted to produce certain popular wellness peptides.

An FDA advisory panel has voted to recommend expanding legal access to six popular peptide compounds, citing concerns about the existing grey market for these therapies.

Moderna's flu vaccine has received a unanimous endorsement from an FDA advisory panel, moving it closer to potential approval.

A U.S. FDA advisory panel is set to review seven popular peptides to determine if they can be compounded by licensed pharmacies. Despite potential regulatory hurdles, industry experts anticipate continued strong consumer demand for these substances.